Thyroid Cancer Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theThyroid Cancer Diagnostics Market?
The surge in thyroid cancer cases is stimulating the growth of the market for thyroid cancer diagnostics. Thyroid cancer is a condition that occurs in the thyroid gland, an organ at the throat’s base responsible for generating hormones that control body temperature, heart rate, blood pressure, and weight. Diagnostics for thyroid cancer aid in early detection, enhancing the possibility of successful treatment. Hence, the rise in thyroid cancer cases escalates the need for the diagnostic market. For example, a report by the American Cancer Society, a non-profit organization in the U.S., projected about 43,720 new thyroid cancer cases in September 2023, with 12,540 in men and 31,180 in women. The report also predicted around 2,120 deaths from this type of cancer in the same year, including 970 men and 1,150 women. Therefore, the increased occurrence of thyroid cancer is fueling the growth of the thyroid cancer diagnostic market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12030&type=smp
What is the Predicted Annual Growth Rate of theThyroid Cancer Diagnostics Market Impact Industry Trends by 2034?
The market sphere for thyroid cancer diagnostics has seen robust growth in the latest years. The market is projected to escalate from $2.99 billion in 2024, reaching $3.16 billion in 2025, maintaining a compound annual growth rate (CAGR) of 5.7%. The previous growth is attributed to a rise in thyroid cancer cases, an aging demographic, heightened awareness leading to early detection, government strategies and financing, along with superior healthcare infrastructure.
In the forthcoming years, the thyroid cancer diagnostics market is projected to witness robust growth. The market size is predicted to reach $4.01 billion by 2029, expanding at a compound annual growth rate (CAGR) of 6.2%. Factors contributing to this expected growth in the forecasting phase include the mounting requirement for companion diagnostics, the increasing inclination of patients towards personalized medicine, and economic growth coupled with healthcare expenditure. Also, training and education of physicians and regulatory approvals and clearances are vital factors. Key trends expected during the forecast period comprise liquid biopsies, globalization of diagnostic technologies, technological enhancements, R&D activities, incorporation of AI along with collaborations and partnerships.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12030
What Are the Current Market Growth and Trends in theThyroid Cancer Diagnostics Market That Industry Players Should Watch?
Leading players in the thyroid cancer diagnostic market are spearheading the introduction of novel solutions such as RNA sequencing tests to improve the precision of cancer fusion detection in a wide spectrum of solid tumors, including thyroid cancer. RNA sequencing (RNA-Seq) is a potent technique that facilitates the assessment of the quantity and sequence of RNA present in a sample, yielding valuable perspectives on gene expression and comprehensive transcriptomic data. For example, in March 2024, the biotechnology firm based in the United States, Foundation Medicine, Inc., unveiled the FoundationOne RNA, an RNA sequencing test using tissue samples to identify cancer-associated gene fusions across 318 genes in the U.S. market. This test can provide fusion reports for all types of solid tumors and could be especially helpful in pinpointing fusions in cancers such as non-small cell lung cancer (NSCLC), sarcoma, pancreatic cancer, thyroid cancer, cholangiocarcinoma, and bladder cancer.
What Are the Major Market Players Making an Impact on theThyroid Cancer Diagnostics Market Growth?
Major companies operating in the thyroid cancer diagnostics market include Pfizer Inc., General Electric, F. Hoffmann-La Roche AG, Bayer AG, Novartis International AG, Sanofi S.A., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Toshiba Corporation, Merck KGaA, Siemens Healthcare GmbH, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., AstraZeneca plc, Agilent Technologies Inc., Hologic Inc., Genzyme Corporation, Illumina Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Quest Diagnostics Inc., Qiagen N.V., Cepheid, Veracyte Inc., DiaSorin S.p.A., Myriad Genetics Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/thyroid-cancer-diagnostics-global-market-report
How Are the Key Segments of the Thyroid Cancer Diagnostics Market Driving Opportunities and Innovations?
The thyroid cancer diagnostics market covered in this report is segmented –
1) By Technique Type: Imaging Test, Blood Test, Biopsy, Other Test Type
2) By Disease Type: Papillary Carcinoma, Follicular Carcinoma, Other Diseases
3) By End-User: Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Other End-Users
Subsegments:
1) By Imaging Test: Ultrasound Imaging, Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scans, Radioactive Iodine Scans
2) By Blood Test: Thyroid Function Tests, Tumor Marker Tests, Genetic Testing For Thyroid Cancer
3) By Biopsy: Fine Needle Aspiration (FNA) Biopsy, Core Needle Biopsy, Surgical Biopsy
4) By Other Test Type: Molecular Diagnostics, Immunohistochemistry Tests, Histopathological Analysis
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12030&type=smp
What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theThyroid Cancer Diagnostics Market?# Market Expansion?
North America was the largest region in the thyroid cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Gobal Thyroid Cancer Diagnostics Maret 2025, By The Business Research Company:
Automotive Light Emitting Diode (LED) Bulbs Global Market Report 2024
Electric Motor And Generator Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/electric-motor-and-generator-global-market-report
Automobiles And Heavy Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
